GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Gushengtang Holdings Ltd (HKSE:02273) » Definitions » EBIT

Gushengtang Holdings (HKSE:02273) EBIT : HK$348 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gushengtang Holdings EBIT?

Gushengtang Holdings's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was HK$144 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$348 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Gushengtang Holdings's annualized ROC % for the quarter that ended in Jun. 2024 was 13.40%. Gushengtang Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 58.20%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Gushengtang Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 5.02%.


Gushengtang Holdings EBIT Historical Data

The historical data trend for Gushengtang Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gushengtang Holdings EBIT Chart

Gushengtang Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial -165.23 -246.87 -599.52 241.57 338.80

Gushengtang Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 72.68 172.33 134.43 204.37 143.89

Competitive Comparison of Gushengtang Holdings's EBIT

For the Medical Care Facilities subindustry, Gushengtang Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gushengtang Holdings's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gushengtang Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gushengtang Holdings's EV-to-EBIT falls into.



Gushengtang Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$348 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gushengtang Holdings  (HKSE:02273) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Gushengtang Holdings's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=290.838 * ( 1 - 14.24% )/( (1839.181 + 1883.597)/ 2 )
=249.4226688/1861.389
=13.40 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3696.253 - 621.791 - ( 1456.491 - max(0, 774.642 - 2009.923+1456.491))
=1839.181

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3655.563 - 611.111 - ( 1272.074 - max(0, 693.838 - 1854.693+1272.074))
=1883.597

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Gushengtang Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=287.776/( ( (485.04 + max(-289.516, 0)) + (503.913 + max(-28.492, 0)) )/ 2 )
=287.776/( ( 485.04 + 503.913 )/ 2 )
=287.776/494.4765
=58.20 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(196.8 + 167.293 + 19.012) - (621.791 + 0 + 50.83)
=-289.516

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(221.083 + 171.74 + 189.796) - (611.111 + 0 + 0)
=-28.492

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Gushengtang Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=348.254/6940.578
=5.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gushengtang Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Gushengtang Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Gushengtang Holdings Business Description

Traded in Other Exchanges
Address
No. 419, Qingsha Road, Room 005, Dongchong Town, Nansha District, Guangzhou, CHN
Gushengtang Holdings Ltd is a traditional Chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. As all of the Group's revenue is derived from the PRC.
Executives
Tu Zhiliang 2501 Other
Wumianshan Ltd. 2201 Interest of corporation controlled by you
Frandor Limited
Tu Family Holdings Limited
Trident Trust Company (singapore) Pte. Limited
Dream True Limited
Action Thrive Group Limited 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Eight Roads Holdings Limited 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Eight Roads Shareholdings Limited 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Johnson Iv Edward C. 2301 Trustee
Johnson Abigail P. 2301 Trustee

Gushengtang Holdings Headlines

No Headlines